Structural Formula (Image 1)
Methylphenidate Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 62037-727
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 62037-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Image 2)
Figure2 (Image 3)
Figure 3 (Image 4)
This appears to be a table of results from a study comparing the effects of Methylphenidate HCI extended-release tablets to a placebo on the Combined Attention Subscale. The table displays the scores at various times post-initial dose for both the group that received the medication and the group that received the placebo. The table also notes the sample size and shows the mean and standard error of the mean.*
1 (Image 5)
This is a medication guide for Methylphenidate Hydrochloride extended release tablets. The tablets come in a bottle of 100 and contain 18 mg USP. Patients are advised to take only one tablet once daily as indicated in the package insert. The pharmacist should dispense the accompanying medication guide to each patient. The medication should be stored between 20°C and 25°C (68°F and 77°F), and protected from humidity. The package is serialized coded.*
1 (Image 6)
This is a description for a medication containing methylphenidate hydrochloride in extended-release tablets. It's intended for once-daily use and comes with a medication guide that should be given to every patient. The typical dose should be found in the package insert. The medication should be stored between 20°C to 25°C, with permissible excursions to 15°C to 30°C. It should be protected from humidity and stored in a tight container with a child-resistant closure. This medication should be kept out of reach of children. The manufacturer is Teva Pharmaceuticals, and it contains 100 tablets. The text includes a code for serialization at the end.*
1 (Image 7)
This is a description for Once-Daily Methylphenidate Hydrochloride Extended-Release Tablets, USP by Teva Pharmaceuticals. It is a prescription medication that comes in a container with 100 tablets. The usual dosage is once a day, and each tablet contains 36 mg of Methylphenidate hydrochloride USP (an extended-release formulation). Pharmacist is advised to dispense the medication guide to each patient. The medication should be stored at a temperature between 20°C to 25°C, with humidity protection. It must be kept out of children's reach, in a tight and light-resistant container. The description also provides the address and contact details of the manufacturer (Teva Pharmaceuticals Parsippany, NJ 07054). However, there is no information available about its usage and effects.*
1 (Image 8)
This is a medication guide for the pharmaceutical drug Methylphenidate Hydrochloride, an extended-release medication in tablet form. It is recommended for daily use and comes in a bottle of 100 tablets. The medication should be stored within the temperature range of 20° to 25°C (68° to 77°F). Patients should be instructed to keep the medication out of the reach of children. In addition, it is the pharmacist's responsibility to provide a Medication Guide to each patient. The rest of the text contains instructions for dispensing and manufacturing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
